Literature DB >> 17171741

Economic cost of dementia patients according to the limitation of the activities of daily living in Korea.

Im Ok Kang1, Sang-Yi Lee, Su Young Kim, Chong Yon Park.   

Abstract

BACKGROUND: Dementia is expected to become a significant social burden in the future. However, there are few reports that have estimated the total economic cost of dementia, particularly according to the limitation in the activities of daily living (ADL) in Korea.
OBJECTIVES: This study is to analyze the health care expenditures and cost per dementia patient, and estimated the total economic cost of dementia.
METHODS: Caregivers of 609 dementia patients, who were randomly selected from a nationwide claim database of the Korean National Health Insurance Corporation, were interviewed using structured questionnaire in the period of September 2005. The total cost including the direct and indirect costs during a year was calculated. The patients were stratified into three limitation groups according to their ADL score. The cost according to the three limitation groups was analyzed. The national cost of dementia patients was then estimated.
RESULTS: The total cost per dementia patient in Korea was $7,462. The direct and indirect costs were $6,626 and $836 per patient, respectively. The cost increased with increasing degree of limitation in the patient's ADL. Over a 1-year period, the total cost per patient in the low limitation group was lower ($3,698) than that of the moderate ($6,064) and high ($11,428) limitation group.
CONCLUSIONS: This study demonstrates that the direct and indirect costs of dementia are considerately small for patients with lower limitation in their ADL. The total economic cost of dementia per year was estimated to be in the range of 1.3 to 3.3 billion dollars on assumptions in Korea.

Entities:  

Mesh:

Year:  2007        PMID: 17171741     DOI: 10.1002/gps.1729

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  8 in total

Review 1.  Alzheimer's disease: the strength of association of costs with different measures of disease severity.

Authors:  J Mauskopf; J Racketa; E Sherrill
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Formal and Informal Care of Community-Living Older People: A Population-Based Study from the Swedish National Study on Aging and Care.

Authors:  A Wimo; S Elmståhl; L Fratiglioni; B-M Sjölund; A Sköldunger; C Fagerström; J Berglund; M Lagergren
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Costs of Hospitalization for Dementia in Urban China: Estimates from Two Urban Health Insurance Scheme Claims Data in Guangzhou City.

Authors:  Hui Zhang; Donglan Zhang; Yujie Yin; Chao Zhang; Yixiang Huang
Journal:  Int J Environ Res Public Health       Date:  2019-08-03       Impact factor: 3.390

4.  Impact of physical activity on activity of daily living in moderate to severe dementia: a critical review.

Authors:  Elisabeth Burge; Nicolas Kuhne; André Berchtold; Christine Maupetit; Armin von Gunten
Journal:  Eur Rev Aging Phys Act       Date:  2011-12-15       Impact factor: 3.878

5.  The cost of dementia in an unequal country: The case of Chile.

Authors:  Daniel A Hojman; Fabian Duarte; Jaime Ruiz-Tagle; Marilu Budnich; Carolina Delgado; Andrea Slachevsky
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

6.  Introducing big data analysis using data from National Health Insurance Service.

Authors:  EunJin Ahn
Journal:  Korean J Anesthesiol       Date:  2020-05-13

7.  Longitudinal Study-Based Dementia Prediction for Public Health.

Authors:  HeeChel Kim; Hong-Woo Chun; Seonho Kim; Byoung-Youl Coh; Oh-Jin Kwon; Yeong-Ho Moon
Journal:  Int J Environ Res Public Health       Date:  2017-08-30       Impact factor: 3.390

8.  Gender-Based Analysis of Risk Factors for Dementia Using Senior Cohort.

Authors:  Jaekue Choi; Lee-Nam Kwon; Heuiseok Lim; Hong-Woo Chun
Journal:  Int J Environ Res Public Health       Date:  2020-10-05       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.